Search
-
Can't beat them? ...then copy them!
Richard Garnham, Innovation Manager, looks at what the new Instagram Stories feature will mean for brands, and the platform’s competitors like Snapchat.
-
Is party politics broken?
On 13 July 2016, The Spectator held a discussion on the future of party politics. On the panel: The Spectator’s political editor James Forsyth, journalist Sir Simon Jenkins, Ben Page and Professor Colleen Graffy, who was US deputy assistant secretary of state in the George W. Bush administration.
-
Cheetahs, Chickens and Goldfish
Speed is good when it comes to customer service and beating competition. But it can sometimes be a mixed blessing, writes Andrew Green.
-
Ladders to social mobility after Brexit
Ben Marshall looks at whether Brexit is a “smell the coffee” moment for a different approach to social mobility and housing tenure.
-
4 ways the anti-immigration vote won the referendum for Brexit
Total control on immigration mattered more to voters than the single market, writes Aalia Khan in the New Statesman.
-
Newsbrands need to harness VR to keep pace with digital life
News organisations shouldn't wait for YouTube to take over the Virtual Reality space, writes Neil Stevenson, Research Manager, Ipsos Connect in Mediatel.
-
Females and the younger generation tend to share more selfies on social media
Ipsos Connect's Tech Tracker is a quarterly, GB nationally representative research survey which measures the emerging trends and developments in technology.
-
Who'll win the European referendum? It all depends on the young
If the young don't turn out, the result will be Brexit, writes Bobby Duffy in the New Statesman.
-
Five questions business leaders should ask before they speak out on Brexit
With just four weeks to go until referendum day, Milorad Ajder of the Ipsos Reputation Centre looks at our recent research and asks: should you be taking a public stance?
-
Brexit and the UK pharma industry
Eleanor Biggs of Ipsos Healthcare asks what Brexit could mean for the UK pharmaceutical industry in PharmExec.com.